The regulation of health technologies is a critical component of every country's public health system and ensures that high-quality, safe health technologies reach the people who need them most. Unfortunately, the capacity of many low- and middle-income countries (LMICs) to evaluate and approve health technologies—and to monitor their safety, efficacy, and quality—is limited, due to inadequate resources, overburdened staff, and incoherent policy frameworks.